tirzepatide and skin rash & Zepbound Injection-Site Reactions: Causes, Treatment, and Prevention rash from tirzepatide injection Hives
Description
In the STEP and SURMOUNT trials for semaglutide and tirzepatide respectively, weight loss curves generally began to flatten between weeks 36 and 60, reflecting the physiological set point adaptation that occurs as appetite suppression becomes partially offset by metabolic adaptation
A 2.5 mg dose is 2.5 10 = 0.25 mL = 25 units
Qian Y, Zhang Y, Fan X, et al
Tirzepatide, also known as Zepbound, is an FDA-approved dual GLP-1/GIP receptor agonist designed to help manage weight effectively
It is generally recommended to avoid or strictly limit alcohol when taking this combination
